Mingfen Lv
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Immunotherapy and Immune Responses
Papers in
-
- Mycobacterium research and diagnosis 1
-
- Psoriasis: Treatment and Pathogenesis 2
- Immunotherapy and Immune Responses 1
- Co-authors
- Yunsheng Xu (5 shared papers)Rongying Ou (7 shared papers)Shan Fang (1 shared paper)Yu Gao (1 shared paper)Jingjing Liu (3 shared papers)Jia Liu (1 shared paper)Shun Lu (1 shared paper)Tian Li (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Tumor Biology (1 paper)The FASEB Journal (1 paper)Cell Biology International (1 paper)Photodiagnosis and Photodynamic Therapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Mingfen Lv
13 papers receiving 330 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 130
- Immunology 62
- Molecular Biology 182
- Hepatology 19
- Epidemiology 63
Countries citing papers authored by Mingfen Lv
This map shows the geographic impact of Mingfen Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfen Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfen Lv more than expected).
Fields of papers citing papers by Mingfen Lv
This network shows the impact of papers produced by Mingfen Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfen Lv. The network helps show where Mingfen Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfen Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 66 | |
| 2 | 2018 | 66 | |
| 3 | 2017 | 59 | |
| 4 | 2015 | 24 | |
| 5 | 2020 | 21 | |
| 6 | 2023 | 18 | |
| 7 | 2019 | 17 | |
| 8 | 2021 | 16 | |
| 9 | 2019 | 12 | |
| 10 | 2020 | 11 | |
| 11 | 2021 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2021 | 7 |
About Mingfen Lv
Mingfen Lv is a scholar working on Epidemiology, Immunology, Molecular Biology, Cancer Research and Dermatology, having authored 13 papers that have together received 334 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Endometrial and Cervical Cancer Treatments (1 paper), Enzyme-mediated dye degradation (1 paper), Ferroptosis and cancer prognosis (1 paper), Vitamin C and Antioxidants Research (1 paper), Mycobacterium research and diagnosis (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Cancer Research (130 citations), Immunology (62 citations), Molecular Biology (182 citations), Hepatology (19 citations) and Epidemiology (63 citations). Mingfen Lv has collaborated with scholars based in China and United States. Frequent co-authors include Yunsheng Xu, Rongying Ou, Shan Fang, Yu Gao, Jingjing Liu, Jia Liu, Shun Lu, Tian Li, Luhui Wang and Liang Zhao. Their work appears in journals such as Frontiers in Oncology, Tumor Biology, The FASEB Journal, Cell Biology International and Photodiagnosis and Photodynamic Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.